Evolus (EOLS) EBITDA Margin (2019 - 2026)
Evolus (EOLS) recorded EBITDA Margin of -2.62% in Q2 2026, up 9.59 percentage points from -12.21% a year earlier and up 3.53 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) EBITDA Margin (2019 - 2026) Analysis & Trends
On a TTM basis, Evolus' EBITDA Margin came in at -3.09% as of Jun 30, 2026, up 10.37 percentage points year-over-year; for FY2025, it came in at -8.47%, up 2.47 percentage points from FY2024.
- Annual EBITDA Margin has increased for three straight years, with a five-year change of +249.83 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -10.93% in FY2024 (+10.89 pp), -21.82% in FY2023 (+19.63 pp), -41.45% in FY2022 (-2.54 pp) and -38.91% in FY2021 (+219.39 pp).
- Quarterly EBITDA Margin has ranged from -68.17% in Q3 2021 to 7.17% in Q4 2025 over the past five years.
- On a year-over-year basis, EBITDA Margin has increased for four consecutive quarters, with an average year-over-year change of +5.34 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 466.50 percentage points in Q4 2021, against a drop of 125.01 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -6.16% (Q1 2026), 7.17% (Q4 2025) and -13.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Evolus | 525.47 Mn | 333.16 Mn | 57.18 Mn | -2.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.62% |
| Mar 31, 2026 | -6.16% |
| Dec 31, 2025 | 7.17% |
| Sep 30, 2025 | -13.85% |
| Jun 30, 2025 | -12.21% |
| Mar 31, 2025 | -19.86% |
| Dec 31, 2024 | -1.19% |
| Sep 30, 2024 | -23.55% |
| Jun 30, 2024 | -9.38% |
| Mar 31, 2024 | -12.66% |
| Dec 31, 2023 | -11.91% |
| Sep 30, 2023 | -24.25% |
| Jun 30, 2023 | -28.11% |
| Mar 31, 2023 | -25.98% |
| Dec 31, 2022 | -22.02% |
| Sep 30, 2022 | -50.08% |
| Jun 30, 2022 | -55.15% |
| Mar 31, 2022 | -42.84% |
| Dec 31, 2021 | -49.36% |
| Sep 30, 2021 | -68.17% |
API Access
Evolus EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();